Meridian Bio R&D brings together four connected offerings — Drug Discovery Consulting, Discovery & Pre-Clinical, Lab Digitisation, and AI — on one FAIR data foundation, helping partners move faster from the bench to the clinic.
"Accelerating the path from the bench to the clinic."
We combine a bench-to-bedside screening and repurposing capability with an intelligence layer that helps scientists search, reason, predict, and report — so more programs reach clinical candidacy, faster.
Strategic advisory, embedded discovery leadership, and practical guidance across the pipeline — from target to candidate.
Assay development, compound screening, and disease-relevant profiling that de-risk and feed drug discovery before the clinic.
ELN and LIMS, instrument and assay integration, and screening pipelines that make every result structured and reusable.
A native agentic AI layer that reasons across your data to turn it into decisions, always within the scientist's context.
An established screening and repurposing platform with a real project and publication track record.
A native agentic AI layer that turns screening data into decisions — in the scientist's context.
Work with pharma, academic, and funding partners to run campaigns and advance programs.
Tell us about your target, your program, or your interest in the AI offering. We work with pharma and biotech partners, academic collaborators, and funders.
Partnerships & Enquiries
We'd welcome a conversation about screening campaigns, collaborations, or early access to the AI offering.